New12

New12

New12 related products

Structure Cat No. Product Name CAS No. Product Description
V33166 Arginase inhibitor 1 1345808-25-4 Arginase inhibitor 1 is a novel, potent and selective inhibitor of human arginases I and II (IC50s = 223 and 509 nM, respectively) with the potential for treatment of myocardial reperfusion injury.
V6429 Aripiprazole lauroxil 1259305-29-7 Aripiprazole lauroxil (RDC3317; RDC-3317; ALKS 9070; ALKS-9072; Abilify; Aristada) is a long-acting injectable atypical antipsychotic approved in 2015 by FDA mainly forthe treatment of schizophrenia and bipolar disorder.
V29259 Artemisic acid 80286-58-4 Artemisic acid(Qing Hao acid) is a naturally occurring amorphane sesquiterpene found inArtemisia annua L.
V11681 Ascorbyl palmitate 137-66-6 Ascorbyl palmitate is a novel and potent fat-soluble vitamin C analogue(ester formed from ascorbic acid and palmitic acid).
V29118 Astragaloside I (Astrasieversianin IV; Cyclosieversioside B) 84680-75-1 Astragaloside I (Astrasieversianin IV; Cyclosieversioside B) is a natural product found inAstragalus membranaceus withosteogenic activity.
V11783 AT-1015 HCl 190508-50-0 AT-1015 HCl is a novel, potent and selective 5-HT2A serotonin receptor antagonist that is known to impair platelet aggregation and vasoconstriction.
V23997 Atorvastatin calcium trihydrate (CI981; liptonorm) 344423-98-9 Atorvastatin calcium trihydrate ( CI-981) is a potent and selectiveinhibitor of HMG-CoA reductase primarily used as a cholesterol-lowering medication that blocks the production of cholesterol.
V11913 AV-105 1205550-99-7 AV-105 is a precursor to the synthesis of Florbetapir (18F), which is a positron emission tomography (PET) scanning radiopharmaceutical agent used for PET imaging of neurodegenerative diseases of the brain such asAlzheimer's disease.
V11947 Avenanthramide C 116764-15-9 Avenanthramide C inhibits vascular smooth muscle cell proliferation and enhances nitric oxide production.
V41257 Avibactam Impurity 6 1192651-49-2 Avibactam Impurity 6 is an impurity of Avibactam (NXL-104; NXL104; Avycaz), which is a non-β lactam β-lactamase inhibitor that inactivates β-lactamases and has been approved for use in combination withceftazidime (trade name Avycaz) for treating bacterial infections.
V11956 AVN-101 HCl 1061354-48-0 AVN-101 HCl (AVN101; AVN 101), the hydrochloride salt of AVN-101, is a novel and potent 5-HT7 receptor antagonist with the potential to be used for the treatment of CNS disorders.
V7698 Axitinib sulfoxide (AG028458; PF03482595) 1347304-18-0 Axitinib sulfoxide (also known as AG-028458; PF-03482595) is a primary and S-oxidized metabolite of Axitinib, an investigational anticancer drug.
V5790 Bamaquimast 135779-82-7 Bamaquimast (F 10126; L 0042) is an effective antiasthmatic agent.
V29257 Basimglurant (RO 491752; RG-7090) 1034442-21-1 Basimglurant (RG7090; RO491752) is a potent, selective and orally bioavailable mGlu5 negative allosteric modulator with a Kd of 1.1 nM.
V12298 Batefenterol Succinate 945905-37-3 Batefenterol (formerly known as GSK961081 and TD-5959) is a novel, potent and selectivemuscarinicreceptor antagonist andβ2-adrenoceptoragonist; it displays high affinity for hM2, hM3 muscarinic and hβ2-adrenoceptor withKivalues of 1.4, 1.3 and 3.7 nM, respectively.
V29096 BCECF 85138-49-4 BCECF is a novel fluorescent agent/dyewhich apH-sensitive andhas been widely used as an indicator of cytosolic pH.
V30394 Beclamide 501-68-8 Beclamide is a bioactive molecule with anticonvulsant (antiepileptic/antiseizure) activity and works as an anticonvulsant (antiepileptic/antiseizure).
V8233 Bendroflumethiazide 73-48-3 Bendroflumethiazide (Benuron;Bendrofluazide; Bentride) is a orally bioactive diuretic andan antihypertensive agentused to treat hypertension.
V9600 Benfluorex 23602-78-0 Benfluorex (Mediator) is an anorectic and hypolipidemic agent that is structurally related to fenfluramine.
V12382 Benfluorex HCl 23642-66-2 Benfluorex (Mediator) is an anorectic and hypolipidemic agent that is structurally related to fenfluramine.
Contact Us Back to top